Where does Rex Medical, L.P. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Rex Medical, L.P. ranks #4,393 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Rex Medical, L.P. hold?

Rex Medical, L.P. holds 81 US utility patents granted between 2015 and 2025, spanning 10 technology areas.

What is Rex Medical, L.P.'s Innovation Score?

Rex Medical, L.P. has an Innovation Score of 38.6 out of 100 (top 40% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Rex Medical, L.P. focus on?

Rex Medical, L.P.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 66 patents, ranking #278 of 7,127 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

Is Rex Medical, L.P.'s patent grant rate increasing or decreasing?

Rex Medical, L.P.'s recent grant velocity is -64% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Rex Medical, L.P.'s patents?

Rex Medical, L.P.'s patents average 16.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Rex Medical, L.P. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Rex Medical, L.P.

USPTO PatentsView assignee record - 81 granted patents across 10 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Rex ranks #4,393 of 49,997 tracked US assignees by granted-patent volume, with 81 patents across 10 technology areas.

#4,393
of 49,997 US assignees by volume: Top 40%
by Innovation Score (38.6/100): 16.6
avg claims per patent: -64%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R4393 · US Corporation #4,393 · 81 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 81 grants
TOP-DECILE #4,393/49,997
PHOTO-FINISH Obrist Closures…
CPC-FOCUS A61B · 10 areas
INNOV-THIN 38.6/100
CLAIMS-RICH 16.6 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -64% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Obrist Closures Switzerland GMBH (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Rex’s 38.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 15.2 pts (39%) Velocity 2.2 pts (6%) Breadth 11.2 pts (29%) Claim depth 10.0 pts (26%)

Qualcomm Incorporated · highest

85
Babyliss Faco SRL · near

39
Foamix Pharamaceutic… · near

39
Prismatic Sensors AB · near

39
Rex Medical · this assignee

39
TangoMe · near

39
3D Lighting… · lowest

7

What this shows Rex's Innovation Score is 38.6/100 (top 40% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Rex?

Each dot is one of Rex’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Rex’s own 16.6 claims/patent is ABOVE the 10.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Rex vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Rex's grants concentrate

Rex Medical, L.P. is a focused PatentsView assignee: 10 CPC subclasses with 81.5% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2019 (15 grants) versus a trough of 1 in 2023. By volume, Rex sits between Obrist Closures Switzerland GMBH and Sheltered Wings, Inc..

Rex's three-year grant acceleration

From 2019–2021 to 2022–2024, Rex Medical, L.P. moved from 27 to 9 grants (0.33x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Obrist Closures S…

81
Onkyo

81
Pierre Fabre MÉDi…

81
Poly-america

81
Shinshu University

81
Seattle Children'…

81
Sercomm

81
Sheltered Wings

81
Rex Medical ◀

81

What this shows Rex holds 81 patents at rank #4,392, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Rex

By rank, the assignees closest to #4,392 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Rex's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Rex, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Rex ranks #278 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (39 here).

Babyliss Faco SRL 39 Foamix Pharamaceuticals Ltd. 39 Prismatic Sensors AB 39 TangoMe, Inc 39

Similar claim depth

Nearest assignees by average claims per patent (16.6 here).

Brandeis University 16.6 avg University of Pittsburgh—Of the Commonwealth System of Higher Education 16.6 avg Applied Materials, Inc. 16.6 avg University OF North Texas 16.6 avg

Rex's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 40% higher than 60% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Rex Medical, L.P. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	9	11.1%
2016	9	11.1%
2017	11	13.6%
2018	14	17.3%
2019	15	18.5%
2020	7	8.6%
2021	5	6.2%
2022	7	8.6%
2023	1	1.2%
2024	1	1.2%
2025partial year	2	2.5%

Which technologies does Rex Medical, L.P. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 66

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 18

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 17

G06F - Electric Digital Data Processing 6

A42B - HATS; Head Coverings 4

Y10T - Technical Subjects Covered BY Former US Classification 2

G01L - Measuring Force, Stress, Torque, Work, Mechanical Power, Mechanical Efficiency, OR Fluid Pressure 2

G08B - Signalling OR Calling SYSTEMS; Order TELEGRAPHS; Alarm Systems 2

Y10S - Technical Subjects Covered BY Former Uspc Cross-reference ART Collections [XRACs] AND Digests 1

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 1

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Rex Medical, L.P.'s patent record in context - here's where to go next.

Rex Medical, L.P.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 81.5% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #4,393 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Rex Medical, L.P. against Obrist Closures Switzerland GMBH, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 38.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.